Literature DB >> 3347346

Meningeal carcinomatosis: origin of local IgG production in the CSF.

H I Schipper1, A Bardosi, C Jacobi, K Felgenhauer.   

Abstract

We found that eight of 22 patients with meningeal carcinomatosis from different primary tumors produced local IgG in the CSF, as indicated by elevated IgG index and/or oligoclonal IgG subfractions. Local IgG production, when present, appears in an early stage of the leptomeningeal manifestation and remains detectable over extended observation periods. In autopsied cases with local IgG production, we observed numerous perivascular round-cell infiltrates containing plasma cells and large lymphocytes within the leptomeningeal tumor tissue. After incubation with immunoperoxidase, only these cells showed IgG-specific staining, indicating the site of local IgG production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3347346     DOI: 10.1212/wnl.38.3.413

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

2.  Tumour necrosis factor-alpha in malignant melanomatous meningitis.

Authors:  M Weller; A Stevens; N Sommer; H Wiethölter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

Review 3.  Leptomeningeal metastases: a review of evaluation and treatment.

Authors:  M C Chamberlain
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

4.  Intrathecal IgM response in disseminated cerebrospinal metastasis from malignant melanoma.

Authors:  M Weller; A Stevens; N Sommer; H Wiethölter
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

5.  Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics.

Authors:  Lena Bönig; Nora Möhn; Jonas Ahlbrecht; Ulrich Wurster; Peter Raab; Wolfram Puppe; Kurt-Wolfram Sühs; Martin Stangel; Thomas Skripuletz; Philipp Schwenkenbecher
Journal:  Front Neurol       Date:  2019-08-20       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.